1. Home
  2. XENE vs AGYS Comparison

XENE vs AGYS Comparison

Compare XENE & AGYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • AGYS
  • Stock Information
  • Founded
  • XENE 1996
  • AGYS 1963
  • Country
  • XENE Canada
  • AGYS United States
  • Employees
  • XENE N/A
  • AGYS 2200
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • AGYS EDP Services
  • Sector
  • XENE Health Care
  • AGYS Technology
  • Exchange
  • XENE Nasdaq
  • AGYS Nasdaq
  • Market Cap
  • XENE 3.2B
  • AGYS 3.5B
  • IPO Year
  • XENE 2014
  • AGYS N/A
  • Fundamental
  • Price
  • XENE $43.87
  • AGYS $125.94
  • Analyst Decision
  • XENE Strong Buy
  • AGYS Strong Buy
  • Analyst Count
  • XENE 11
  • AGYS 5
  • Target Price
  • XENE $53.55
  • AGYS $139.20
  • AVG Volume (30 Days)
  • XENE 782.5K
  • AGYS 206.0K
  • Earning Date
  • XENE 11-03-2025
  • AGYS 10-27-2025
  • Dividend Yield
  • XENE N/A
  • AGYS N/A
  • EPS Growth
  • XENE N/A
  • AGYS N/A
  • EPS
  • XENE N/A
  • AGYS 0.86
  • Revenue
  • XENE $7,500,000.00
  • AGYS $299,809,000.00
  • Revenue This Year
  • XENE N/A
  • AGYS $16.52
  • Revenue Next Year
  • XENE $207.88
  • AGYS $17.16
  • P/E Ratio
  • XENE N/A
  • AGYS $146.66
  • Revenue Growth
  • XENE N/A
  • AGYS 17.77
  • 52 Week Low
  • XENE $26.74
  • AGYS $63.71
  • 52 Week High
  • XENE $44.23
  • AGYS $145.25
  • Technical
  • Relative Strength Index (RSI)
  • XENE 68.37
  • AGYS 55.23
  • Support Level
  • XENE $39.09
  • AGYS $118.00
  • Resistance Level
  • XENE $42.31
  • AGYS $127.41
  • Average True Range (ATR)
  • XENE 1.48
  • AGYS 4.65
  • MACD
  • XENE 0.31
  • AGYS -0.94
  • Stochastic Oscillator
  • XENE 99.40
  • AGYS 53.20

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About AGYS Agilysys Inc.

Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.

Share on Social Networks: